Evidence map›Paper›PMID 12643190›Full record

ReviewCurrent diabetes reports2002

Endothelium, inflammation, and diabetes.

Paresh Dandona

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current diabetes reports, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 87 citations in OpenAlex.

  1. Trial
  2. Article
  3. Dementia in Diabetes: The Role of Hypoglycemia.International journal of molecular sciences · 2023
    Review
  4. Review
  5. Review
  6. Review
  7. TRIM21 Mitigates Human Lung Microvascular Endothelial Cells' Inflammatory Responses to LPS.American journal of respiratory cell and molecular biology · 2019
    Article
  8. Perioperative Management of Hyperglycemia and Diabetes in Cardiac Surgery Patients.Endocrinology and metabolism clinics of North America · 2018
    Review
  9. Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.The Journal of clinical endocrinology and metabolism · 2017
    Review
  10. Diabetes mellitus and cognitive impairments.World journal of diabetes · 2016
    Review
  11. Insulin dysfunction and Tau pathology.Frontiers in cellular neuroscience · 2014
    Review
  12. Review
  13. Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.Endocrinology and metabolism clinics of North America · 2013
    Review
  14. Article
  15. Review
  16. Management of hyperglycemia in hospitalized patients.Annals of the New York Academy of Sciences · 2010
    Review
  17. Article
  18. Analytical and biological variation of biomarkers of oxidative stress during the menstrual cycle.Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals · 2008
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Paresh DandonaSUNY Buffalo, Kaleida, Health, 3 Gates Circle, Buffalo, NY 14209, USA. pdandona@kaleidahealth.org
Kaleida Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The endothelium has several diverse functions in maintaining vascular integrity in terms of structure and function. Two key vasodilators, nitric oxide (NO) and prostacyclin, maintain the vascular pathway, inhibit platelet aggregation, and are antithrombotic. More recently, they have been shown to be anti-inflammatory, and thus are potentially antiatherogenic. It has recently been noted that insulin stimulates NO release by the endothelium. Insulin is a vasodilator, has antiplatelet activity, and is anti-inflammatory. Similar anti-inflammatory effects of thiazolidinediones (TZDs), troglitazone and rosiglitazone, suggest that they too may have potential antiatherogenic effects. These effects of insulin and TZDs are important because the two major states of insulin resistance, obesity and type 2 diabetes, are associated with a marked increase in atherosclerosis coronary heart disease, and stroke. These recent observations have extremely momentous implications for the understanding of the pathogenesis of atherosclerosis in insulin-resistant states and for a rational approach to their comprehensive treatment, including the prevention of atherosclerosis and its complications.

Indexed as

ThiazolidinedionesAnimalsAnti-Inflammatory AgentsArteriosclerosisDiabetes ComplicationsDiabetes MellitusDiabetic AngiopathiesEndothelium, VascularGlucoseHumansInsulinOxidative StressThiazolesVasculitis2,4-thiazolidinedioneAnti-Inflammatory AgentsGlucoseInsulinThiazolesThiazolidinediones

Identifiers

PMID12643190
OpenAlexW2111947855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.